હોમ › પ્રોસ્ટેટ કેન્સર › વોશિંગ્ટન › Seattle
Seattle, WA માં પ્રોસ્ટેટ કેન્સર ક્લિનિકલ ટ્રાયલ્સ
Seattle (લગભગ 30 માઇલની અંદર) ની સાઇટ્સ પર પ્રોસ્ટેટ કેન્સર માટે 42 અભ્યાસો ભાગીદારો શોધી રહ્યા છે. કોઈ અભ્યાસ ખોલો અને જુઓ કે કોઈ જોડાઈ શકે છે અને અભ્યાસ ટીમ સાથે સંપર્ક કેવી રીતે કરવો.
અધિકૃત અભ્યાસ ટેક્સ્ટ (અંગ્રેજી)
અહીં અભ્યાસ માટે ભરતી કરી રહ્યા છો? આ પેજની ટોચ પર તેને ફીચર કરો — 30 દિવસ માટે $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ભરતી ચાલુ છેફેઝ 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- અને 1 વધુ
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
ભરતી ચાલુ છેફેઝ 1
- Swedish Medical Center, Seattle
Precision-Based Genomics in Prostate Cancer
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- University of Washington, Seattle
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Research Center, Seattle
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
ભરતી ચાલુ છેફેઝ 2/3
- Fred Hutchinson Cancer Research Center, Seattle
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
ભરતી ચાલુ છેફેઝ 3
- Swedish Medical Center, Seattle
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
ભરતી ચાલુ છેફેઝ 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
ભરતી ચાલુ છેફેઝ 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
ભરતી ચાલુ છેફેઝ 3
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- University of Washington Medical Center, Seattle
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
ભરતી ચાલુ છેફેઝ 2
- University of Washington, Seattle
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ભરતી ચાલુ છેફેઝ 3
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
ભરતી ચાલુ છેફેઝ 1
- Investigational Site Number: 400, Seattle
Prostate Active Surveillance Study
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
ભરતી ચાલુ છેફેઝ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
ભરતી ચાલુ છેફેઝ 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
ભરતી ચાલુ છેફેઝ 2
- University of Washington Medical Center, Seattle
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
ભરતી ચાલુ છેફેઝ 2
- Fred Hutchinson Cancer Center, Seattle
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ભરતી ચાલુ છેફેઝ 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- અને 4 વધુ
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ભરતી ચાલુ છેફેઝ 2
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
ભરતી ચાલુ છેફેઝ 2
- Fred Hutchinson Cancer Center, Seattle
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
ભરતી ચાલુ છેફેઝ 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
ભરતી ચાલુ છેફેઝ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
ભરતી ચાલુ છેફેઝ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
ભરતી ચાલુ છે
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ભરતી ચાલુ છેફેઝ 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- અને 4 વધુ
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
ભરતી ચાલુ છેફેઝ 1
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
ભરતી ચાલુ છેફેઝ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
ભરતી ચાલુ છેફેઝ 2
- VA Puget Sound Health Care System, Seattle
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ભરતી ચાલુ છેફેઝ 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
ભરતી ચાલુ છેફેઝ 2
- Swedish Medical Center-Ballard Campus, Seattle
- FHCC South Lake Union, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
- અને 4 વધુ
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Massive Bio SYNERGY-AI site, Seattle
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ભરતી ચાલુ છેફેઝ 3
- FHCC South Lake Union, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
અન્ય શહેરોમાં પ્રોસ્ટેટ કેન્સર ટ્રાયલ્સ
- New York City, NY103 અભ્યાસો
- Houston, TX76 અભ્યાસો
- Los Angeles, CA61 અભ્યાસો
- Boston, MA59 અભ્યાસો
- St. Louis, MO46 અભ્યાસો
- Chicago, IL45 અભ્યાસો
- San Francisco, CA45 અભ્યાસો
- Philadelphia, PA44 અભ્યાસો
- Baltimore, MD43 અભ્યાસો
- Nashville, TN42 અભ્યાસો
- Washington, DC38 અભ્યાસો
- Dallas, TX36 અભ્યાસો
Seattle માં અન્ય અભ્યાસો
- નોન-સ્મોલ સેલ લંગ કેન્સર53 અભ્યાસો
- કેન્સર (બધા પ્રકાર)49 અભ્યાસો
- એક્યુટ માયલોઇડ લ્યુકેમિયા40 અભ્યાસો
- સ્તન કેન્સર39 અભ્યાસો
- મેટાસ્ટેટિક કેન્સર39 અભ્યાસો
- કોલોરેક્ટલ કેન્સર34 અભ્યાસો
- ફેફસાનું કેન્સર33 અભ્યાસો
- ઓવેરિયન કેન્સર30 અભ્યાસો
- મલ્ટિપલ માયલોમા22 અભ્યાસો
- માયેલોડિસ્પ્લાસ્ટિક સિન્ડ્રોમ્સ21 અભ્યાસો
- એક્યુટ લિમ્ફોબ્લાસ્ટિક લ્યુકેમિયા21 અભ્યાસો
- મૂત્રાશયનો કેન્સર21 અભ્યાસો
ClinicalTrials.gov પરથી, તારીખ 5 ઑક્ટો, 2026 ના ડેટા સાથે. દરેક અભ્યાસની પોતાની પાત્રતા શરતો હોય છે; અભ્યાસ ટીમ નક્કી કરે છે કે કોઈ જોડાઈ શકે છે કે નહીં.